Anti-VEGF therapy for the treatment of glaucoma: a focus on ranibizumab and bevacizumab.
about
Neovascular glaucoma: a reviewThe era of anti-vascular endothelial growth factor (VEGF) drugs in ophthalmology, VEGF and anti-VEGF therapyRanibizumab versus bevacizumab for ophthalmic diseases related to neovascularisation: a meta-analysis of randomised controlled trials.Assessment of patient pain experience during intravitreal 27-gauge bevacizumab and 30-gauge ranibizumab injectionEfficacy of intravitreal ranibizumab combined with Ahmed glaucoma valve implantation for the treatment of neovascular glaucoma.Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term.Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma.Neovascular events in eyes with central retinal vein occlusion undergoing serial bevacizumab or ranibizumab intravitreal injections: a retrospective reviewManagement of neovascular glaucoma with intravitreal ranibizumab, panretinal photocoagulation, and subsequent 5-fluorouracil augmented trabeculectomy: A case reportGlaucoma, Stem Cells, and Gene Therapy: Where Are We Now?
P2860
Q28067262-85B45D7A-E506-4A7D-AFFA-1E41FE61A882Q28067341-544FCE8A-AC3B-460E-B170-D9F27C44F11DQ33830753-A2C59A13-851E-4309-B018-950B1DD308D2Q35657290-BF30C001-FBB4-4304-B843-3A6F3CA1C239Q35889573-D9F55684-D1FA-49A6-9B42-EF542BC44C82Q36117471-579B5383-3D58-427A-84C2-533085894ED8Q37672460-EFE487B6-4E00-42DB-BCEF-CA898B397029Q38364703-FB113D40-DBE8-4A38-937D-D33BD6B3844AQ41045252-F2928D00-E16A-4CAE-9FF2-EF185B90E8F8Q45871232-47AF7A78-6128-49F7-BC9D-84220A809011
P2860
Anti-VEGF therapy for the treatment of glaucoma: a focus on ranibizumab and bevacizumab.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Anti-VEGF therapy for the treatment of glaucoma: a focus on ranibizumab and bevacizumab.
@en
Anti-VEGF therapy for the treatment of glaucoma: a focus on ranibizumab and bevacizumab.
@nl
type
label
Anti-VEGF therapy for the treatment of glaucoma: a focus on ranibizumab and bevacizumab.
@en
Anti-VEGF therapy for the treatment of glaucoma: a focus on ranibizumab and bevacizumab.
@nl
prefLabel
Anti-VEGF therapy for the treatment of glaucoma: a focus on ranibizumab and bevacizumab.
@en
Anti-VEGF therapy for the treatment of glaucoma: a focus on ranibizumab and bevacizumab.
@nl
P2093
P2860
P1476
Anti-VEGF therapy for the treatment of glaucoma: a focus on ranibizumab and bevacizumab.
@en
P2093
Celso Tello
Sung Chul Park
P2860
P304
P356
10.1517/14712598.2012.721772
P407
P577
2012-09-10T00:00:00Z